Grown Rogue International（GRUS.F）株式概要グロウン・ローグ・インターナショナル社はクラフト・カンナビスの会社で、プレミアム・フラワーとフラワー由来製品に焦点を当てている。 詳細GRUS.F ファンダメンタル分析スノーフレーク・スコア評価3/6将来の成長0/6過去の実績0/6財務の健全性5/6配当金0/6報酬当社が推定した公正価値より54.2%で取引されている リスク分析過去5年間で収益は年間17%減少しました。 意味のある時価総額がありません ( $98M )すべてのリスクチェックを見るGRUS.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.3957.6% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-11m102m2016201920222025202620282031Revenue US$102.4mEarnings US$15.1mAdvancedSet Fair ValueView all narrativesGrown Rogue International Inc. 競合他社Cumberland PharmaceuticalsSymbol: NasdaqGS:CPIXMarket cap: US$88.0mJushi HoldingsSymbol: OTCPK:JUSH.FMarket cap: US$89.9mbioteSymbol: NasdaqGM:BTMDMarket cap: US$70.8mStablecoin DevelopmentSymbol: NYSEAM:SDEVMarket cap: US$70.2m価格と性能株価の高値、安値、推移の概要Grown Rogue International過去の株価現在の株価CA$0.3952週高値CA$0.5252週安値CA$0.27ベータ-1.121ヶ月の変化1.63%3ヶ月変化3.46%1年変化3.55%3年間の変化186.07%5年間の変化166.34%IPOからの変化451.71%最新ニュースお知らせ • May 14Grown Rogue International Inc. Revises Revenue Guidance for the Year 2026Grown Rogue International Inc. revised revenue guidance for the year 2026. For the year, the company expected revenue guidance to a range of $34 million to $37 million (up from $32 million to $35 million).お知らせ • Apr 27Grown Rogue International Inc. to Report Q1, 2026 Results on May 12, 2026Grown Rogue International Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 12, 2026お知らせ • Apr 09Grown Rogue International Inc. Provides Earnings Guidance for 2026 and 2027Grown Rogue International Inc. provided earnings guidance for 2026 and 2027. For 2026, the company expects revenue of $32- $35 million. For 2027, the company expects revenue of $50 - $58 million.お知らせ • Apr 01Grown Rogue International Inc. to Report Fiscal Year 2025 Final Results on Apr 07, 2026Grown Rogue International Inc. announced that they will report fiscal year 2025 final results on Apr 07, 2026お知らせ • Mar 31Grown Rogue International Inc. announced delayed annual 10-K filingOn 03/30/2026, Grown Rogue International Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 18Grown Rogue International Inc. to Report Q4, 2025 Results on Mar 31, 2026Grown Rogue International Inc. announced that they will report Q4, 2025 results After-Market on Mar 31, 2026最新情報をもっと見るRecent updatesお知らせ • May 14Grown Rogue International Inc. Revises Revenue Guidance for the Year 2026Grown Rogue International Inc. revised revenue guidance for the year 2026. For the year, the company expected revenue guidance to a range of $34 million to $37 million (up from $32 million to $35 million).お知らせ • Apr 27Grown Rogue International Inc. to Report Q1, 2026 Results on May 12, 2026Grown Rogue International Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 12, 2026お知らせ • Apr 09Grown Rogue International Inc. Provides Earnings Guidance for 2026 and 2027Grown Rogue International Inc. provided earnings guidance for 2026 and 2027. For 2026, the company expects revenue of $32- $35 million. For 2027, the company expects revenue of $50 - $58 million.お知らせ • Apr 01Grown Rogue International Inc. to Report Fiscal Year 2025 Final Results on Apr 07, 2026Grown Rogue International Inc. announced that they will report fiscal year 2025 final results on Apr 07, 2026お知らせ • Mar 31Grown Rogue International Inc. announced delayed annual 10-K filingOn 03/30/2026, Grown Rogue International Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 18Grown Rogue International Inc. to Report Q4, 2025 Results on Mar 31, 2026Grown Rogue International Inc. announced that they will report Q4, 2025 results After-Market on Mar 31, 2026お知らせ • Oct 21Grown Rogue International Inc. to Report Q3, 2025 Results on Nov 11, 2025Grown Rogue International Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025お知らせ • Jul 21Grown Rogue International Inc. to Report Q2, 2025 Results on Aug 12, 2025Grown Rogue International Inc. announced that they will report Q2, 2025 results After-Market on Aug 12, 2025お知らせ • May 02Grown Rogue International Inc., Annual General Meeting, Jul 03, 2025Grown Rogue International Inc., Annual General Meeting, Jul 03, 2025.お知らせ • Apr 10Grown Rogue International Inc. to Report Q1, 2025 Results on May 13, 2025Grown Rogue International Inc. announced that they will report Q1, 2025 results on May 13, 2025お知らせ • Feb 03Grown Rogue International Inc. Appoints Josh Rosen as Chief Strategy OfficerGrown Rogue International Inc. announced the hiring of Josh Rosen as the Company's new Chief Strategy Officer. As CSO, Josh will be responsible for leading Grown Rogue's capital allocation, business development and communication strategy, all in support of helping the Company execute on its vision to build a national craft cannabis brand. Prior to joining the Company, Josh has held numerous positions in the cannabis industry including Executive Chairman and CEO of 4Front Ventures and Chief Executive Officer of Vireo Growth Inc. Before joining 4Front in cannabis, Josh worked as a private equity portfolio manager, with the family office of John Sperling, who was a prominent drug reform philanthropist, and before that as an investment research analyst, primarily with Credit Suisse. Josh continues to serve as a Managing Partner of Bengal Capital, a cannabis investment and advisory firm.お知らせ • Jan 02+ 1 more updateGrown Rogue International Inc. Appoints Andrew Marchington as Chief Financial OfficerGrown Rogue International Inc. appointed Andrew Marchington as the Company's new Chief Financial Officer and Corporate Secretary effective January 1, 2025. Ryan Kee will remain a member of the board of directors supporting the Company with his industry and financial reporting expertise. Andrew Marchington joined the Company as the Senior Vice President, Finance in June 2023. Prior to joining the Company, Andrew served as the Chief Financial Officer of Chalice Brands Ltd. and as Controller of C21 Investments Inc. Andrew is a licensed CPA in Oregon and has served a variety of finance and accounting roles both in and outside of the cannabis industry.お知らせ • Jun 06Grown Rogue Receives Licensing Approval Approval with the New Jersey Cannabis Regulatory CommissionGrown Rogue International Inc. announced it has received licensing approval with the New Jersey Cannabis Regulatory Commission ("CRC") and closed its first option to acquire 44% of ABCO Garden State, LLC ("ABCO") on May 31, 2024. The transaction details are as follows: Grown Rogue has an option to acquire 70% of ABCO through two options; Option 1 was for 44% and Option 2 is for 26% ABCO has an annual cultivation license with the New Jersey Cannabis Regulatory Commission with local zoning and planning approvals and sufficient power supply Upon receiving licensing approval, the Company purchased Option 1 for USD 1,260,000, which has been paid in cash The Company anticipates exercising Option 2, pending regulatory approval, two years after operations commence. The purchase price for Option 2 is USD 720,000 Grown Rogue has the right to purchase the remaining equity of ABCO at fair market value.お知らせ • Apr 26Grown Rogue International Inc., Annual General Meeting, Jun 24, 2024Grown Rogue International Inc., Annual General Meeting, Jun 24, 2024.お知らせ • Mar 03Grown Rogue International Inc. announced delayed 20-F filingOn 03/01/2024, Grown Rogue International Inc. announced that they will be unable to file their next 20-F by the deadline required by the SEC.お知らせ • Jul 14Grown Rogue International Inc. announced that it has received $5 million in funding from Mindset CapitalOn July 13, 2023, Grown Rogue International Inc. closed the transaction. The transaction was led by retuning investor, Mindset Capital. Additionally, on closing, the company issued to the subscribers under the offering an aggregate of 13,737,500 common share purchase warrants.お知らせ • Jul 07Grown Rogue International Inc., Annual General Meeting, Oct 24, 2023Grown Rogue International Inc., Annual General Meeting, Oct 24, 2023.お知らせ • Jul 06Grown Rogue International Inc. announced that it expects to receive $5 million in fundingGrown Rogue International Inc. announced a non-brokered private placement of unsecured convertible debentures with an aggregate principal amount of up to $5,000,000 on July 4, 2023. Each subscriber under the offering shall receive one-half of one common share purchase warrant for each CAD 0.24 ($0.18) of principal amount subscribed. The debentures will mature four years from the closing date, bear interest at a rate equal to 9% per annum, payable in united states currency on the last business day of the month following the end of each calendar quarter and are convertible as set forth below into common shares of the company. The debenture holders will be entitled, at their option, to convert, at any time on or prior to the maturity date, the outstanding Principal Amount and accrued interest into shares at a price per share equal to CAD 0.24 ($0.18). The company may elect to prepay the principal amount together with any interest thereon prior to the maturity date upon providing 30 days’ notice to the debenture holder. Each full Warrant will be exercisable into one share at an exercise price of CAD 0.28 ($0.21) for a period of three years from the closing date and are subject to an acceleration clause that in the event that the shares close at or above CAD 0.40 ($0.30) per share on the Canadian Securities Exchange for ten consecutive trading days, the warrant expiry date shall accelerate to 90 days following notice of the acceleration event. The offering is expected to close in multiple tranches within 30 days, with the first closing occurring on or about July 14, 2023. The debentures, the warrants as well as the underlying shares, will be subject to a statutory hold period for a period of four months and one day from the closing date. The company may, at its option, increase the offering by an additional $1,000,000 for gross proceeds of up to $6,000,000.株主還元GRUS.FUS PharmaceuticalsUS 市場7D4.4%5.3%1.1%1Y3.6%44.3%28.7%株主還元を見る業界別リターン: GRUS.F過去 1 年間で44.3 % の収益を上げたUS Pharmaceuticals業界を下回りました。リターン対市場: GRUS.Fは、過去 1 年間で28.7 % のリターンを上げたUS市場を下回りました。価格変動Is GRUS.F's price volatile compared to industry and market?GRUS.F volatilityGRUS.F Average Weekly Movement11.0%Pharmaceuticals Industry Average Movement9.9%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%安定した株価: GRUS.F 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: GRUS.Fの 週次ボラティリティ ( 11% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/an/aJesse Stricklerwww.grownrogue.comグロウン・ローグ・インターナショナル社はクラフト・カンナビスの会社で、プレミアム・フラワーとフラワー由来製品に注力している。消費者向けに様々な品種を生産しており、それらはインディカ、サティバ、ハイブリッドに分類される。同社は調剤薬局を通じて製品を販売している。グロウン・ローグ・インターナショナルは1978年に設立され、オレゴン州メドフォードに本社を置いている。もっと見るGrown Rogue International Inc. 基礎のまとめGrown Rogue International の収益と売上を時価総額と比較するとどうか。GRUS.F 基礎統計学時価総額US$97.70m収益（TTM）-US$1.57m売上高(TTM)US$34.43m2.8xP/Sレシオ-62.2xPER（株価収益率GRUS.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計GRUS.F 損益計算書（TTM）収益US$34.43m売上原価US$20.01m売上総利益US$14.42mその他の費用US$15.99m収益-US$1.57m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-0.0063グロス・マージン41.88%純利益率-4.56%有利子負債／自己資本比率54.6%GRUS.F の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 22:18終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Grown Rogue International Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Siddharth RajeevFundamental Research Corp.
お知らせ • May 14Grown Rogue International Inc. Revises Revenue Guidance for the Year 2026Grown Rogue International Inc. revised revenue guidance for the year 2026. For the year, the company expected revenue guidance to a range of $34 million to $37 million (up from $32 million to $35 million).
お知らせ • Apr 27Grown Rogue International Inc. to Report Q1, 2026 Results on May 12, 2026Grown Rogue International Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 12, 2026
お知らせ • Apr 09Grown Rogue International Inc. Provides Earnings Guidance for 2026 and 2027Grown Rogue International Inc. provided earnings guidance for 2026 and 2027. For 2026, the company expects revenue of $32- $35 million. For 2027, the company expects revenue of $50 - $58 million.
お知らせ • Apr 01Grown Rogue International Inc. to Report Fiscal Year 2025 Final Results on Apr 07, 2026Grown Rogue International Inc. announced that they will report fiscal year 2025 final results on Apr 07, 2026
お知らせ • Mar 31Grown Rogue International Inc. announced delayed annual 10-K filingOn 03/30/2026, Grown Rogue International Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 18Grown Rogue International Inc. to Report Q4, 2025 Results on Mar 31, 2026Grown Rogue International Inc. announced that they will report Q4, 2025 results After-Market on Mar 31, 2026
お知らせ • May 14Grown Rogue International Inc. Revises Revenue Guidance for the Year 2026Grown Rogue International Inc. revised revenue guidance for the year 2026. For the year, the company expected revenue guidance to a range of $34 million to $37 million (up from $32 million to $35 million).
お知らせ • Apr 27Grown Rogue International Inc. to Report Q1, 2026 Results on May 12, 2026Grown Rogue International Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 12, 2026
お知らせ • Apr 09Grown Rogue International Inc. Provides Earnings Guidance for 2026 and 2027Grown Rogue International Inc. provided earnings guidance for 2026 and 2027. For 2026, the company expects revenue of $32- $35 million. For 2027, the company expects revenue of $50 - $58 million.
お知らせ • Apr 01Grown Rogue International Inc. to Report Fiscal Year 2025 Final Results on Apr 07, 2026Grown Rogue International Inc. announced that they will report fiscal year 2025 final results on Apr 07, 2026
お知らせ • Mar 31Grown Rogue International Inc. announced delayed annual 10-K filingOn 03/30/2026, Grown Rogue International Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 18Grown Rogue International Inc. to Report Q4, 2025 Results on Mar 31, 2026Grown Rogue International Inc. announced that they will report Q4, 2025 results After-Market on Mar 31, 2026
お知らせ • Oct 21Grown Rogue International Inc. to Report Q3, 2025 Results on Nov 11, 2025Grown Rogue International Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025
お知らせ • Jul 21Grown Rogue International Inc. to Report Q2, 2025 Results on Aug 12, 2025Grown Rogue International Inc. announced that they will report Q2, 2025 results After-Market on Aug 12, 2025
お知らせ • May 02Grown Rogue International Inc., Annual General Meeting, Jul 03, 2025Grown Rogue International Inc., Annual General Meeting, Jul 03, 2025.
お知らせ • Apr 10Grown Rogue International Inc. to Report Q1, 2025 Results on May 13, 2025Grown Rogue International Inc. announced that they will report Q1, 2025 results on May 13, 2025
お知らせ • Feb 03Grown Rogue International Inc. Appoints Josh Rosen as Chief Strategy OfficerGrown Rogue International Inc. announced the hiring of Josh Rosen as the Company's new Chief Strategy Officer. As CSO, Josh will be responsible for leading Grown Rogue's capital allocation, business development and communication strategy, all in support of helping the Company execute on its vision to build a national craft cannabis brand. Prior to joining the Company, Josh has held numerous positions in the cannabis industry including Executive Chairman and CEO of 4Front Ventures and Chief Executive Officer of Vireo Growth Inc. Before joining 4Front in cannabis, Josh worked as a private equity portfolio manager, with the family office of John Sperling, who was a prominent drug reform philanthropist, and before that as an investment research analyst, primarily with Credit Suisse. Josh continues to serve as a Managing Partner of Bengal Capital, a cannabis investment and advisory firm.
お知らせ • Jan 02+ 1 more updateGrown Rogue International Inc. Appoints Andrew Marchington as Chief Financial OfficerGrown Rogue International Inc. appointed Andrew Marchington as the Company's new Chief Financial Officer and Corporate Secretary effective January 1, 2025. Ryan Kee will remain a member of the board of directors supporting the Company with his industry and financial reporting expertise. Andrew Marchington joined the Company as the Senior Vice President, Finance in June 2023. Prior to joining the Company, Andrew served as the Chief Financial Officer of Chalice Brands Ltd. and as Controller of C21 Investments Inc. Andrew is a licensed CPA in Oregon and has served a variety of finance and accounting roles both in and outside of the cannabis industry.
お知らせ • Jun 06Grown Rogue Receives Licensing Approval Approval with the New Jersey Cannabis Regulatory CommissionGrown Rogue International Inc. announced it has received licensing approval with the New Jersey Cannabis Regulatory Commission ("CRC") and closed its first option to acquire 44% of ABCO Garden State, LLC ("ABCO") on May 31, 2024. The transaction details are as follows: Grown Rogue has an option to acquire 70% of ABCO through two options; Option 1 was for 44% and Option 2 is for 26% ABCO has an annual cultivation license with the New Jersey Cannabis Regulatory Commission with local zoning and planning approvals and sufficient power supply Upon receiving licensing approval, the Company purchased Option 1 for USD 1,260,000, which has been paid in cash The Company anticipates exercising Option 2, pending regulatory approval, two years after operations commence. The purchase price for Option 2 is USD 720,000 Grown Rogue has the right to purchase the remaining equity of ABCO at fair market value.
お知らせ • Apr 26Grown Rogue International Inc., Annual General Meeting, Jun 24, 2024Grown Rogue International Inc., Annual General Meeting, Jun 24, 2024.
お知らせ • Mar 03Grown Rogue International Inc. announced delayed 20-F filingOn 03/01/2024, Grown Rogue International Inc. announced that they will be unable to file their next 20-F by the deadline required by the SEC.
お知らせ • Jul 14Grown Rogue International Inc. announced that it has received $5 million in funding from Mindset CapitalOn July 13, 2023, Grown Rogue International Inc. closed the transaction. The transaction was led by retuning investor, Mindset Capital. Additionally, on closing, the company issued to the subscribers under the offering an aggregate of 13,737,500 common share purchase warrants.
お知らせ • Jul 07Grown Rogue International Inc., Annual General Meeting, Oct 24, 2023Grown Rogue International Inc., Annual General Meeting, Oct 24, 2023.
お知らせ • Jul 06Grown Rogue International Inc. announced that it expects to receive $5 million in fundingGrown Rogue International Inc. announced a non-brokered private placement of unsecured convertible debentures with an aggregate principal amount of up to $5,000,000 on July 4, 2023. Each subscriber under the offering shall receive one-half of one common share purchase warrant for each CAD 0.24 ($0.18) of principal amount subscribed. The debentures will mature four years from the closing date, bear interest at a rate equal to 9% per annum, payable in united states currency on the last business day of the month following the end of each calendar quarter and are convertible as set forth below into common shares of the company. The debenture holders will be entitled, at their option, to convert, at any time on or prior to the maturity date, the outstanding Principal Amount and accrued interest into shares at a price per share equal to CAD 0.24 ($0.18). The company may elect to prepay the principal amount together with any interest thereon prior to the maturity date upon providing 30 days’ notice to the debenture holder. Each full Warrant will be exercisable into one share at an exercise price of CAD 0.28 ($0.21) for a period of three years from the closing date and are subject to an acceleration clause that in the event that the shares close at or above CAD 0.40 ($0.30) per share on the Canadian Securities Exchange for ten consecutive trading days, the warrant expiry date shall accelerate to 90 days following notice of the acceleration event. The offering is expected to close in multiple tranches within 30 days, with the first closing occurring on or about July 14, 2023. The debentures, the warrants as well as the underlying shares, will be subject to a statutory hold period for a period of four months and one day from the closing date. The company may, at its option, increase the offering by an additional $1,000,000 for gross proceeds of up to $6,000,000.
